Physician profile
Theodore F Schlegel
NPI 1689670028
$5,030,009.70
in general payments reported to CMS, 2019-2025
11 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $4.0M · 2021: $866K · 2022: $45K · 2023: $120K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $130K · Food and Beverage: $269 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $130,194.06 |
| Food and Beverage | $268.67 |
| Travel and Lodging | $234.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,939,536.20 | 2020 | |
| Medtronic, INC. | $654,412.61 | 2021-2025 | Ellipsys Vascular Access System |
| Kaleo, INC. | $385,198.06 | 2020-2021 | |
| Smith+Nephew, INC. | $49,774.92 | 2019-2022 | |
| Peerless Surgical INC. | $478.75 | 2023 | |
| Stryker Corporation | $363.99 | 2019-2020 | |
| Motive Health, INC. | $103.47 | 2019 | |
| Avenu Medical INC. | $60.27 | 2020 | |
| Pacira Therapeutics, INC. | $36.65 | 2020 | |
| Arthrex, INC. | $24.00 | 2023 | |
| Depuy Synthes Sales INC. | $20.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,036,377.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Schlegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.